Quadramet

Drug Lantheus Medical Imaging, Inc.
Total Payments
$1.9M
Transactions
388
Doctors
231
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2019 $544,764 11 1
2018 $621,180 168 123
2017 $694,305 209 141

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1.8M 37 98.2%
Grant $16,129 1 0.9%
Consulting Fee $10,600 4 0.6%
Food and Beverage $5,739 316 0.3%
Travel and Lodging $566.30 1 0.0%
Education $272.60 29 0.0%

Top Doctors Receiving Payments for Quadramet — Page 10

Doctor Specialty Location Total Records
, M.D Hematology & Oncology Rogers, AR $12.04 1
, M.D Hematology & Oncology Fayetteville, AR $12.04 1
, M.D Nuclear Cardiology Cerro Las Mesas, PR $12.00 1
, M.D Hematology & Oncology Birmingham, AL $11.84 1
, M.D Urology Las Vegas, NV $11.59 1
, M.D Internal Medicine San Juan, PR $10.55 1
, MD Internal Medicine Rio Piedras, PR $8.34 1

About Quadramet

Quadramet is a drug associated with $1.9M in payments to 231 healthcare providers, recorded across 388 transactions in the CMS Open Payments database. The primary manufacturer is Lantheus Medical Imaging, Inc..

Payment data is available from 2017 to 2019. In 2019, $544,764 was paid across 11 transactions to 1 doctors.

The most common payment nature for Quadramet is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.8M, 98.2% of total).